Electrospun nanofibrous constructs based on nanoparticles and biopolymers have recently been used in tissue engineering because of their similarity to the extracellular matrix in nature. In this study, electrospun chitosan-carbon quantum dot-titanium dioxide-graphene oxide (CS-CQD-TiO2-GO) nanofibrous mats were synthesized for use as wound dressings by the electrospinning method. To increase the biodegradation rate and water resistance, the fabricated nanofibrous mats were cross-linked. SEM images showed a uniform and coherent structure of CS-CQD-TiO2-GO nanocomposites and CS-CQD-TiO2-GO electrospun nanofibers mats. FTIR analysis, XRD pattern, SEM mapping, and EDS spectrum demonstrate the accuracy of the synthesis as well as the elemental and chemical structure of the nanofibrous mat. The water contact angle indicated that the nanofibrous mat had a hydrophilic property, which is essential for controlling wound exudates. The tensile strength and elongation tests showed that the nanofibrous mat has suitable mechanical properties for wound dressing, including significant flexibility and strength. Interestingly, antimicrobial testing illustrated that the fabricated nanofibrous mat had antibacterial activity against Gram-negative and Gram-positive bacteria. Appropriate cell viability and cytocompatibility of treated mouse fibroblast NIH3T3 cells with the nanofibrous mat were determined using an MTT assay. The animal study results confirmed the proper potential of the nanofibrous mat in wound dressing applications.
Breast cancer remains the most commonly diagnosed malignancy among women worldwide. Standard treatment often involves mastectomy, followed by chemotherapy and/or radiation. Approximately 40% of patients undergo breast reconstruction to address the physical and psychological effects of tissue loss. Since the first autologous breast reconstruction described in 1887, both autologous and alloplastic techniques have evolved significantly to improve patient outcomes. However, current approaches are limited by issues such as the inability to restore biological breast function, suboptimal tissue integration, and concerns over long-term implant viability. Tissue engineering has emerged as a promising field capable of overcoming these limitations. Since the 1990s, advances in biomaterials, stem cell research, and regenerative strategies have enabled the development of vascularized, patient-specific constructs with potential applications in both structural and functional breast reconstruction. This review provides a comprehensive overview of the evolution of breast reconstruction techniques and the integration of tissue engineering into the field. Particular emphasis is placed on tissue engineering’s role in enhancing breast cancer treatment and diagnosis while also exploring future directions toward functional restoration, including lactation.
Burn injury remains a major clinical challenge, causing substantial morbidity, disability, and reconstructive burden. Although autografts remain the gold standard, their use is limited by donor-site scarcity, highlighting the need for patient-specific skin substitutes that combine structural support with regenerative bioactivity. Here, we developed a stem cell-laden 3D-bioprinted skin substitute comprising porcine skin-derived decellularized extracellular matrix (dECM) bioink loaded with autologous burn-derived mesenchymal stem cells (BDMSCs), an innovative and potent source isolated from discarded burn skin, together with a polyurethane/silver nanoparticle supportive layer. The dECM bioink retained extracellular matrix components and regenerative growth factors, supported high-fidelity bioprinting, promoted BDMSC survival, adhesion, migration, infiltration, and proliferation, and supported native-like cell–matrix interactions. In a porcine third-degree burn model, dECM-PU/Ag+BDMSC constructs enhanced epithelialization, collagen maturation, dermal organization, and vascular maturation while reducing contraction, inflammatory infiltration, and fibrotic remodeling. Overall, this platform advances a personalized stem cell-based bioengineered skin substitute for severe burn repair.